Multivalency in Drug Delivery–When Is It Too Much of a Good Thing?

Designer Peptide and Protein Dendrimers: A Cross-Sectional Analysis

Dendrimers have attracted immense interest in science and technology due to their unique chemical structure that offers a myriad of opportunities for researchers. Dendritic design allows us to present peptides in a branched three-dimensional fashion that eventually leads to a globular shape, thus mimicking globular proteins. Peptide dendrimers, unlike other classes of dendrimers, have immense applications in biomedical research due to their biological origin. The diversity of potential building blocks and innumerable possibilities for design, along with the fact that the area is relatively underexplored, make peptide dendrimers sought-after candidates for various applications. This review summarizes the stepwise evolution of peptidic dendrimers along with their multifaceted applications in various fields. Further, the introduction of biomacromolecules such as proteins to a dendritic scaffold, resulting in complex macromolecules with discrete molecular weights, is an altogether new addition to the area of organic chemistry. The synthesis of highly complex and fully folded biomacromolecules on a dendritic scaffold requires expertise in synthetic organic chemistry and biology. Presently, there are only a handful of examples of protein dendrimers; we believe that these limited examples will fuel further research in this area.

On the encapsulation and assembly of anticancer drugs in a cooperative fashion

In this study, we report the remarkable recognition and assembly characteristics of D 3h symmetric basket 1 6- containing two adjoining and nonpolar cavities with six biocompatible GABA residues at their northern and southern termini. From the results of experimental (1H NMR, fluorescence and UV-Vis spectroscopies) and computational (MM-MC/OPLS3e) investigations, we deduced that hexaanionic 1 6- captured two molecules of anticancer drug doxorubicin 2 + in water and accommodated them in its two deep cavities. The formation of stable 1 6-⊂2 2 2+ (K a = 3 × 1012 M-2) was accompanied by the exceptional homotopic cooperativity (α = 4K 2/K 1 = 112) in which K 1 = 3.2 ± 0.8 × 105 M-1 and K 2 = 9 ± 1 × 106 M-1. Furthermore, bolaamphiphilic 1 6-⊂2 2 2+ assembled into spherical nanoparticles (DLS, cryo-TEM and TEM) possessing 41% drug loading. The preorganization of abiotic receptor 1 6- and its complementarity to 2 + have been proposed to play a part in the positive cooperativity in which ten favorable noncovalent contacts (i.e. hydrogen bonds, salt bridges, C-H···π and π-π contacts) are formed between doxorubicin and the dual-cavity host. In the case of topotecan 3 +, however, the absence of multiple and favorable basket⊂drug interactions resulted in the predominant formation of a binary 1 6- ⊂ 3 + complex (K 1 = 2.12 ± 0.01 × 104 M-1) and the negative homotopic allostery (α ≪ 1). To summarize, our study lays out a roadmap for creating a family of novel, accessible and multivalent hosts capable of complexing anticancer agents in a cooperative manner. As basket⊂drug complexes organize into highly loaded nanoparticles, the reported soft material is amenable to the bottom-up construction of stimuli-responsive nanomedicine capable of effective scavenging and/or delivery of drugs.

Ligand density on nanoparticles: A parameter with critical impact on nanomedicine

Nanoparticles modified with ligands for specific targeting towards receptors expressed on the surface of target cells are discussed in literature towards improved delivery strategies. In such concepts the ligand density on the surface of the nanoparticles plays an important role. How many ligands per nanoparticle are best for the most efficient delivery? Importantly, this number may be different for in vitro and in vivo scenarios. In this review first viruses as "biological" nanoparticles are analyzed towards their ligand density, which is then compared to the ligand density of engineered nanoparticles. Then, experiments are reviewed in which in vitro and in vivo nanoparticle delivery has been analyzed in terms of ligand density. These results help to understand which ligand densities should be attempted for better targeting. Finally synthetic methods for controlling the ligand density of nanoparticles are described.

Monitoring glycosidase activity for clustered sugar substrates, a study on β-glucuronidase

Enzymatically-triggered probes to determine glucuronidase hydrolysis kinetics for clustered substrates.